Generic Drugs Making Progress In Market Share By Value

The South African pharmaceutical market is expected to comprise US$2.0bn worth of patented drugs by 2014, underlining our cautious medium-term view that the government will be slow to improve access to medicines through affordability. While the South African public healthcare system continues to function in a state of disarray, with many hospitals understaffed or undersupplied with appropriate medicines and equipment, the prospects for spending in pharmaceuticals are largely limited to the private sector.

To read the full article, please choose one of the following options: